Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY8H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,637
Award facts
- Contract value 100% obligated
- $29,637.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29.6K delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with completion targeted for February 2, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999B through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company has demonstrated consistent capability to fulfill federal pharmaceutical supply requirements through competitive awards of various medications and medical supplies. Tezspire is a biologic treatment used for moderate to severe eosinophilic asthma, and this delivery order represents routine fulfillment of medical supply needs through the established prime vendor contract vehicle designed to provide flexible access to critical pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCY8H?
SPE2DR26FCY8H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FCY8H worth?
The government has obligated $29,637 on SPE2DR26FCY8H.
Is contract SPE2DR26FCY8H an order under another contract?
Yes. SPE2DR26FCY8H is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY8H competed?
The extent of competition for SPE2DR26FCY8H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award